Jacqueline T. Brown
0000-0002-1885-0906
Publication & Citation Trends
Most Cited Works
Publications
120 total
Somatic Yolk Sac Tumors in the Urinary tract: A Form of Rare Divergent Differentiation.
Cited by 0
Semantic Scholar
Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab Trial.
Cited by 1
Semantic Scholar
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
Cited by 11
Semantic Scholar
Phase 2 Study of Perioperative Lenvatinib with Pembrolizumab in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma 3215
Cited by 0
Semantic Scholar
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial OA
Cited by 1
Semantic Scholar
Adjuvant Therapy for Non-Clear Cell Renal Cell Carcinoma-The Ascent Continues. OA
Cited by 2
Semantic Scholar
DIAGNOSTIC DILEMMAS IN PROSTATIC STROMAL-INVASIVE UCC WITH VARIANT HISTOLOGY
Cited by 0
Semantic Scholar
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers PDF
Cited by 42
OpenAlex
Research Topics
Renal cell carcinoma treatment
(38)
Cancer Immunotherapy and Biomarkers
(34)
Bladder and Urothelial Cancer Treatments
(34)
Prostate Cancer Treatment and Research
(14)
Urinary and Genital Oncology Studies
(14)
Frequent Co-Authors
Affiliations
St. Michael's Hospital
Emory University
King's College London
Brown University
University of Virginia Health System